Related Experiment Video
Updated: Aug 24, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Infective endocarditis in adult patients with congenital heart disease
Joost P van Melle1, Jolien W Roos-Hesselink2, Manish Bansal3
1Center for Congenital Heart Diseases, Department of Cardiology, University Medical Center Groningen, University of Groningen, the Netherlands.
Insights
Congenital heart disease patients with infective endocarditis have a better survival rate. Further research is needed on antibiotic prophylaxis efficacy in these patients, especially after dental procedures.
Area of Science:
- Cardiology
- Infectious Diseases
- Clinical Research
Background:
- Congenital Heart Disease (CHD) increases susceptibility to Infective Endocarditis (IE).
- Limited data exists on the characteristics and outcomes of IE in CHD patients.
Purpose of the Study:
- To characterize adult patients with CHD and IE.
- To compare their baseline characteristics and mortality with non-CHD patients.
Main Methods:
- Prospective international study (ESC-EORP-EURO-ENDO) of 3111 IE patients.
- Analysis of 365 adult CHD patients compared to 2746 non-CHD patients.
- Comparison of baseline characteristics and mortality rates.
Main Results:
- CHD patients were younger, had fewer comorbidities, and a higher incidence of prior dental procedures and Streptococcus viridans infections.
- In-hospital mortality was lower in CHD patients (9.0% vs 18.1%).
- Favorable survival in CHD patients during 700-day follow-up (HR 0.68), with mortality predictors including fistula, cerebral embolus, renal insufficiency, Staphylococcus aureus, and missed surgery.
Conclusions:
- CHD patients with IE demonstrate improved overall mortality outcomes.
- High rates of pre-IE dental procedures suggest a need to re-evaluate antibiotic prophylaxis guidelines for CHD patients.
Background:
Congenital Heart Disease (CHD) predisposes to Infective Endocarditis (IE), but data about characterization and prognosis of IE in CHD patients is scarce.
Methods:
The ESC-EORP-EURO-ENDO study is a prospective international study in IE patients (n = 3111). In this pre-specified analysis, adult CHD patients (n = 365, 11.7%) are described and compared with patients without CHD (n = 2746) in terms of baseline characteristics and mortality.
Results:
CHD patients (73% men, age 44.8 ± 16.6 years) were younger and had fewer comorbidities. Of the CHD patients, 14% had a dental procedure before hospitalization versus 7% in non-CHD patients (p < 0.001) and more often had positive blood cultures for Streptococcus viridans (16.4% vs 8.8%, p < 0.001). As in non-CHD patients, IE most often affected the left-sided valves. For CHD patients, in-hospital mortality was 9.0% vs 18.1% in non-CHD patients (p < 0.001), and also, during the entire follow-up of 700 days, survival was more favorable (log-rank p < 0.0001), even after adjustment for age, gender and major comorbidities (Hazard Ratio (HR) 0.68; 95%CI 0.50-0.92). Within the CHD population, multivariable Cox regression revealed the following effects (HR and [95% CI]) on mortality: fistula (HR 6.97 [3.36-14.47]), cerebral embolus (HR 4.64 [2.08-10.35]), renal insufficiency (HR 3.44 [1.48-8.02]), Staphylococcus aureus as causative agent (HR 2.06 [1.11-3.81]) and failure to undertake surgery when indicated (HR 5.93 [3.15-11.18]).
Conclusions:
CHD patients with IE have a better outcome in terms of all-cause mortality. The observed high incidence of dental procedures prior to IE warrants further studies about the current use, need and efficacy of antibiotic prophylaxis in CHD patients.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Mitral Stenosis I: Introduction

